Why the study?
The association between CHF in CHA2DS2-VASc scores and thromboembolic events in AF is debated, prompting evaluation of the score incorporating diastolic parameters into the C criterion.
Does modifying the C criterion of the CHA2DS2-VASc score to include diastolic impairment (E/E' ≥ 11) improve the prediction of composite thromboembolic events in patients with nonvalvular atrial fibrillation?
Does modifying the C criterion of the CHA2DS2-VASc score to include diastolic impairment (E/E' ≥ 11) improve the prediction of composite thromboembolic events in patients with nonvalvular atrial fibrillation?
Defining the congestive heart failure criterion in the CHA2DS2-VASc score using diastolic impairment (E/E' ≥ 11) improves its predictive value for thromboembolic events in patients with nonvalvular atrial fibrillation.
Answers are grounded in this paper and cite their sources.
E/E' ≥11 as CHF criterion may enhance CHA2DS2-VASc prediction in NVAF; hypothesis-generating and requires prospective validation before practice change.
The association between congestive heart failure (CHF) of the CHA2DS2-VASc scores and thromboembolic (TE) events in patients with atrial fibrillation (AF) is a topic of debate due to conflicting results. As the importance of diastolic impairment in the occurrence of TE events is increasingly recognized, it is crucial to evaluate the predictive power of CHA2DS2-VASc scores with C criterion integrating diastolic parameters. We analyzed 4200 Korean nonvalvular AF patients (71 years of age, 59% men) to compare multiple echocardiographic definitions of CHF. Various guideline-suggested echocardiographic parameters for systolic or diastolic impairment, including left ventricular ejection fraction (LVEF) ≤ 40%, the ratio of early diastolic mitral inflow velocity to early diastolic velocity of the mitral annulus (E/E’) ≥ 11, left atrial volume index > 34 mL/m2, and many others were tested for C criteria. Multivariate-adjusted Cox regression analysis showed that CHA2DS2-VASc score was an independent predictor for composite thromboembolic events only when CHF was defined as E/E’ ≥ 11 (hazard ratio, 1.26; p = 0.044) but not with other criteria including the original definition (hazard ratio, 1.10; p = 0.359). Our findings suggest that C criterion defined as diastolic impairment, such as E/E’ ≥ 11, may improve the predictive value of CHA2DS2-VASc scores.
No takes yet. Share an insight, caveat, or question.
Jang et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: